CISA Warned About Critical Vulnerabilities in Illumina's DNA Sequencing Devices

The U.S. Cybersecurity and Infrastructure Security Agency CISA and Food and Drug Administration FDA have issued an advisory about critical security vulnerabilities in Illumina's next-generation sequencing NGS software. Three of the flaws are rated 10 out of 10 for severity on the Common...